Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000947871-16-001217

Director bought 1,712,400 shares at an average $10.42 ($17,849,568)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-05-20 Purchase : show line 1 in the form +2,400 $10.04 $24,096 28,043,404 I
2016-05-23 Purchase : show line 2 in the form +1,191,600 $10.40 $12,392,640 29,235,004 I
2016-05-24 Purchase : show line 3 in the form +518,400 $10.48 $5,432,832 29,753,404 I
Open-market purchases · 1,712,400 sh · avg $10.42 · $17,849,568
Loading xslF345X03/ss1486941_4.xml…